(19)
(11) EP 1 836 322 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
11.01.2017 Bulletin 2017/02

(45) Mention of the grant of the patent:
07.09.2016 Bulletin 2016/36

(21) Application number: 06727428.2

(22) Date of filing: 12.01.2006
(51) International Patent Classification (IPC): 
C12Q 1/68(2006.01)
(86) International application number:
PCT/IB2006/000796
(87) International publication number:
WO 2006/075254 (20.07.2006 Gazette 2006/29)

(54)

METHODS AND PRODUCTS FOR IN VITRO GENOTYPING

VERFAHREN UND PRODUKTE ZUR IN VITRO GENOTYPISIERUNG

PROCEDES ET PRODUITS DE GENOTYPAGE IN VITRO


(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 13.01.2005 ES 200500089
05.10.2005 ES 200502423
12.01.2006 US 758192 P

(43) Date of publication of application:
26.09.2007 Bulletin 2007/39

(73) Proprietor: Progenika Biopharma, S.A.
48160 Derio, Vizcaya (ES)

(72) Inventors:
  • SIMÓN BUELA, Laureano Progenika Biopharma S.A. S.A.
    Parque Tecnológico de Zamudio 48160 Derio, Vizcaya (ES)
  • MARTÍNEZ MARTÍNEZ, Antonio Progenika Biopharma, S.A.
    Parque Tecnológico de Zamudio 48160 Derio, Vizcaya (ES)
  • TEJEDOR HERNÁNDEZ, Diego Progenika Biopharma, S.A.
    Parque Tecnológico de Zamudio 48160 Derio, Vizcaya (ES)
  • JIMÉNEZ URIBE, Elise Progenika Biopharma, S.A.
    Parque Tecnológico de Zamudio 48160 Derio, Vizcaya (ES)
  • LÓPEZ MARTÍNEZ, Monica Progenika Biopharma, S.A.
    Parque Tecnológico de Zamudio 48160 Derio, Vizcaya (ES)
  • ARTIEDA OSEÑALDE, Marta Progenika Biopharma, S.A.
    Parque Tecnológico de Zamudio 48160 Derio, Vizcaya (ES)
  • HERNÁNDEZ GARCÍA, Lorena Progenika Biopharma, S.A.
    Parque Tecnológico de Zamudio 48160 Derio, Vizcaya (ES)

(74) Representative: Casley, Christopher Stuart et al
Mewburn Ellis LLP City Tower 40 Basinghall Street
London EC2V 5DE
London EC2V 5DE (GB)


(56) References cited: : 
WO-A-00/58516
WO-A-01/29269
   
  • KOZAL M.J. ET AL.: "EXTENSIVE POLYMORPHISMS OBSERVED IN HIV-1 CLADE B PROTEASE GENE USING HIGH-DENSITY OLIGONUCLEOTIDE ARRAYS" NATURE MEDICINE, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 2, no. 7, July 1996 (1996-07), pages 753-759, XP000941131 ISSN: 1078-8956
  • HACIA J.G. ET AL.: "DETECTION OF HETEROZYGOUS MUTATIONS IN BRCA1 USING HIGH DENSITY OLIGONUCLEOTIDE ARRAYS AND TWO-COLOUR FLUORESCENCE ANALYSIS" NATURE GENETICS, NEW YORK, NY, US, vol. 14, no. 4, 1 December 1996 (1996-12-01), pages 441-447, XP000615885 ISSN: 1061-4036
  • CHEE M. ET AL.: "ACCESSING GENETIC INFORMATION WITH HIGH-DENSITY DNA ARRAYS" SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 274, 25 October 1996 (1996-10-25), pages 610-614, XP002022508 ISSN: 0036-8075
  • SAPOLSKY R.J. ET AL.: "High-throughput polymorphism screening and genotyping with high-density oligonucleotide arrays" GENETIC ANALYSIS: BIOMOLECULAR ENGINEERING, ELSEVIER SCIENCE PUBLISHING, US, vol. 14, no. 5-6, February 1999 (1999-02), pages 187-192, XP004158703 ISSN: 1050-3862
  • CUTLER D.J. ET AL.: "High-throughput variation detection and genotyping using microarrays" GENOME RESEARCH, COLD SPRING HARBOR LABORATORY PRESS, WOODBURY, NY, US, vol. 11, no. 11, November 2001 (2001-11), pages 1913-1925, XP002311211 ISSN: 1088-9051 cited in the application
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).